Our company news

We are working on the following new projects: • We were awarded with a contract for medical writing activities with pelubiprofen

We are working on the following new projects: • We signed two contracts for data management services for bioequivalence trials with Paroxetine and Desloratadine.

We are working on the following new projects: Smooth signed a contract for a bioequivalence trial with Rivaroxaban.

The International Day of Clinical Research is celebrated on May 20

We are working on the following new projects: • Smooth is starting a new project in acute nasopharyngitis with our long-term Russian client.

We are working on the following new projects: • We were awarded with Rebamipide trial.

We are working on the following new projects: Smooth signed a contract for a trial with Fabomotizole. We were awarded with a medical writing project with INN Budesonide.

We are working on the following new projects: • We were awarded with two phase IV full-service trials of Nimesulide. • We signed four new contracts for BE trials with our Russian sponsor

We are working on the following new projects: • We signed the contract for the development of a scientific article based on the results of the observation program in chronic hepatitis C genotypes 1 to 6 in the Russian Federation.

We are constantly working to improve our IT solutions and now we have set up the eCRF of version 2.0 with advanced data validation capability. New modules

We are working on the following new projects: We signed a new contract for BE trial with our Indian long-term sponsor.

We are working on the following new projects: Our company was awarded with medical writing of an article based on the study report from Chronic Hepatitis C in Russian Federation.

We are working on the following new projects: We are preparing a contract for a phase 1 clinical trial with Dalteparin sodium. Our company signed a contract signature for the observational program with a top ten pharma.

We are working on the following new projects: Smooth is signing a contract for a bioequivalence trial of the Ibuprofen with our long-term client in Russia. Our company started activities for regulatory support for a global CRO.

We are working on the following new projects: • Smooth won a bidding for the international phase III clinical trial of the original drug for the patients with chronic myeloid leukemia. The study will take place in India, Belarus, and Russia.